KRTX — Karuna Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $12.58bn
- $11.32bn
- $0.65m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 389 | 322 | 494 | 1,124 | 1,263 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 1.75 | 0.057 | 0 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 393 | 345 | 517 | 1,155 | 1,315 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.195 | 2.87 | 9.54 | 7.88 | 20.5 |
Other Long Term Assets | |||||
Total Assets | 393 | 348 | 528 | 1,163 | 1,336 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.96 | 6.85 | 20.2 | 33.9 | 68.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.11 | 8.69 | 25.6 | 37.1 | 82 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 390 | 339 | 502 | 1,126 | 1,254 |
Total Liabilities & Shareholders' Equity | 393 | 348 | 528 | 1,163 | 1,336 |
Total Common Shares Outstanding |